October 28, 2024 — “Our results provide a national contemporaneous estimate of the decline in metabolic bariatric surgery associated with the era of GLP-1 RAs.” Writing in JAMA Network Open last week, Kevin Lin, Ateev Mehrotra, and Thomas Tsai say rates of metabolic surgery dropped 26% in 2023 as use of GLP-1 medicines for obesity more than doubled. Nonetheless, […]
December 28, 2023 — This was a year of great progress in obesity, and with that progress came frustrations and angst. So finding the best and worst of 2023 in obesity and health is actually quite an easy and interesting task. Let’s dig right in. #1 Best: Cardiovascular Outcomes Benefit Data for Semaglutide Above all else the landmark findings […]
September 1, 2023 — At IFSO 2023 in Naples, it was clear the people are keenly aware. Change is afoot in obesity care. New obesity medicines are starting to produce clinical outcomes that approach the outcomes people see with surgery So the recurrent question at the meeting was all about what might be on the horizon for metabolic surgery. […]
May 30, 2017 — For many people, food addiction explains obesity. Nevermind that scientists have some problems with the concept. While scientists debate, much of the public is embracing the idea. So what are the implications? Does the idea that people can get hooked on food lead to more or less stigma? Does it help people cope with eating […]
